Regeneron Pharmaceuticals annual shares outstanding
2009
2010
2011
Regeneron Pharmaceuticals Shares Outstanding History (REGN)
Regeneron Pharmaceuticals reported 90.7M shares outstanding at the end of fiscal 2011.
View full Regeneron Pharmaceuticals company overviewRegeneron Pharmaceuticals annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2011 | 2011-12-31 | 90.7M | 3.5M | +3.96% |
| 2010 | 2010-12-31 | 87.2M | 8.4M | +10.62% |
| 2009 | 2009-12-31 | 78.9M | — | — |
Regeneron Pharmaceuticals quarterly shares outstanding
Q4.09
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q3 2012 | 2012-09-30 | 94.4M | 4.0M | +4.41% |
| Q2 2012 | 2012-06-30 | 93.94B | 93.85B | +104961.48% |
| Q1 2012 | 2012-03-31 | 92.97B | 92.88B | +104893.21% |
| Q4 2011 | 2011-12-31 | 90.69B | 90.60B | +103859.01% |
| Q3 2011 | 2011-09-30 | 90.4M | 10.4M | +12.96% |
| Q2 2011 | 2011-06-30 | 89.4M | 9.5M | +11.88% |
| Q1 2011 | 2011-03-31 | 88.5M | 9.7M | +12.28% |
| Q4 2010 | 2010-12-31 | 87.2M | — | — |
| Q3 2010 | 2010-09-30 | 80.0M | — | — |
| Q2 2010 | 2010-06-30 | 79.9M | — | — |
| Q4 2009 | 2009-12-31 | 78.9M | — | — |
Regeneron Pharmaceuticals shares outstanding trends
Across the available reported history, Regeneron Pharmaceuticals's shares outstanding moved from 87.2M to 90.7M, a change of 3.5M. The latest reported quarter, Q3 2012, shows 94.4M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Regeneron Pharmaceuticals filings at SEC.gov ↗